Long non-coding RNA TTN-AS1/microRNA-199a-3p/runt-related transcription factor 1 gene axis regulates the progression of oral squamous cell carcinoma

References

• Yang Y, Chen D, Liu H, et al. Increased expression of lncRNA CASC9 promotes tumor progression by suppressing autophagy-mediated cell apoptosis via the AKT/mTOR pathway in oral squamous cell carcinoma. Cell Death Dis. 2019;10(2):41.
   PubMed Web of Science ®Google Scholar
• Chi AC, Day TA, Neville BW, Chi AC, Day TA, Neville BW. Oral cavity and oropharyngeal squamous cell carcinoma-an update. CA Cancer J Clin. 2015;65(5):401–421.
   PubMed Web of Science ®Google Scholar
• Sasahira T, Kirita T. Hallmarks of cancer-related newly prognostic factors of oral squamous cell carcinoma. Int J Mol Sci. 2018;19(8):2413.
   Web of Science ®Google Scholar
• Pires FR, Ramos AB, Oliveira JB, et al. Oral squamous cell carcinoma: clinicopathological features from 346 cases from a single oral pathology service during an 8-year period. J Appl Oral Sci. 2013;21(5):460–467.
   PubMed Web of Science ®Google Scholar
• Poeta ML, Manola J, Goldwasser MA, et al. TP53 mutations and survival in squamous-cell carcinoma of the head and neck. N Engl J Med. 2007;357(25):2552–2561.
   PubMed Web of Science ®Google Scholar
• Markopoulos AK. Current aspects on oral squamous cell carcinoma. Open Dent J. 2012;6(1):126–130.
   PubMedGoogle Scholar
• Driemel O, Kunkel M, Hullmann M, et al. Diagnosis of oral squamous cell carcinoma and its precursor lesions. J Dtsch Dermatol Ges. 2007;5(12):1095–1100.
   PubMedGoogle Scholar
• Peng WX, Koirala P, Mo YY. LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 2017;36(41):5661–5667.
   PubMed Web of Science ®Google Scholar
• Schmitt AM, Chang HY. Long noncoding RNAs in cancer pathways. Cancer Cell. 2016;29(4):452–463.
   PubMed Web of Science ®Google Scholar
• Wang J, Su Z, Lu S, et al. LncRNA HOXA-AS2 and its molecular mechanisms in human cancer. Clin Chim Acta. 2018;485:229–233.
   PubMed Web of Science ®Google Scholar
• Zhen Q, Gao LN, Wang RF, et al. LncRNA DANCR promotes lung cancer by sequestering miR-216a. Cancer Control. 2018;25(1):1073274818769849.
   Web of Science ®Google Scholar
• Kong X, Duan Y, Sang Y, et al. LncRNA–CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA-215. J Cell Physiol. 2019;234(6):9105–9117.
   PubMed Web of Science ®Google Scholar
• Fang Z, Zhao J, Xie W, et al. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression. Cancer Med. 2017;6(12):2897–2908.
   PubMed Web of Science ®Google Scholar
• Zheng QX, Wang J, Gu XY, et al. TTN-AS1 as a potential diagnostic and prognostic biomarker for multiple cancers. Biomed Pharmacother. 2021;135:111169.
   PubMed Web of Science ®Google Scholar
• Fu SW, Zhang Y, Li S, et al. LncRNA TTN-AS1 promotes the progression of oral squamous cell carcinoma via miR-411-3p/NFAT5 axis. Cancer Cell Int. 2020;20(1):415.
   PubMed Web of Science ®Google Scholar
• Feng H, Wang Q, Xiao W, et al. <p>LncRNA TTN-AS1 regulates miR-524-5p and RRM2 to Promote Breast Cancer Progression. Onco Targets Ther. 2020;13:4799–4811.
   PubMed Web of Science ®Google Scholar
• Fang J, Huang C, Ke J, et al. lncRNA TTN-AS1 facilitates proliferation, invasion, and epithelial-mesenchymal transition of breast cancer cells by regulating miR-139-5p/ZEB1 axis. J Cell Biochem. 2020;121(12):4772–4784.
   Web of Science ®Google Scholar
• Wang JY, Yang Y, Ma Y, et al. Potential regulatory role of lncRNA-miRNA-mRNA axis in osteosarcoma. Biomed Pharmacother. 2020;121:109627.
   PubMed Web of Science ®Google Scholar
• Luo H, Xu C, Le W, et al. lncRNA CASC11 promotes cancer cell proliferation in bladder cancer through miRNA-150. J Cell Biochem. 2019;120(8):13487–13493.
   PubMed Web of Science ®Google Scholar
• Zhao W, Geng D, Li S, et al. HOTAIR influences cell growth, migration, invasion, and apoptosis via the miR-20a-5p/HMGA2 axis in breast cancer. Cancer Med. 2018;7(3):842–855.
   PubMed Web of Science ®Google Scholar
• Wang Z, Ma X, Cai Q, et al. MiR-199a-3p promotes gastric cancer progression by targeting ZHX1. FEBS Lett. 2014;588(23):4504–4512.
   PubMed Web of Science ®Google Scholar
• Deng Y, Zhao F, Hui L, et al. Suppressing miR-199a-3p by promoter methylation contributes to tumor aggressiveness and cisplatin resistance of ovarian cancer through promoting DDR1 expression. J Ovarian Res. 2017;10(1):50.
   PubMed Web of Science ®Google Scholar
• Wei D, Wang W, Shen B, et al. MicroRNA199a5p suppresses migration and invasion in oral squamous cell carcinoma through inhibiting the EMTrelated transcription factor SOX4. Int J Mol Med. 2019;44(1):185–195.
   PubMed Web of Science ®Google Scholar
• Kamachi Y, Ogawa E, Asano M, et al. Purification of a mouse nuclear factor that binds to both the A and B cores of the polyomavirus enhancer. J Virol. 1990;64(10):4808–4819.
   PubMed Web of Science ®Google Scholar
• Ogawa E, Maruyama M, Kagoshima H, et al. PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. Proc Natl Acad Sci U S A. 1993;90(14):6859–6863.
   PubMed Web of Science ®Google Scholar
• Huang G, Shigesada K, Ito K, et al. Dimerization with PEBP2beta protects RUNX1/AML1 from ubiquitin-proteasome-mediated degradation. EMBO J. 2001;20(4):723–733.
   PubMed Web of Science ®Google Scholar
• Liu K, Hu H, Jiang H, et al. RUNX1 promotes MAPK signaling to increase tumor progression and metastasis via OPN in head and neck cancer. Carcinogenesis. 2021;42(3):414–422.
   PubMed Web of Science ®Google Scholar
• Scheitz CJ, Lee TS, McDermitt DJ, et al. Defining a tissue stem cell-driven Runx1/Stat3 signalling axis in epithelial cancer. EMBO J. 2012;31(21):4124–4139.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Lu X, Chen L, Li Y, et al. Long non-coding RNA LINC01207 promotes cell proliferation and migration but suppresses apoptosis and autophagy in oral squamous cell carcinoma by the microRNA-1301-3p/lactate dehydrogenase isoform A axis. Bioengineered. 2021.
   Web of Science ®Google Scholar
• Chen L, Zhu Q, Lu L, et al. MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1. Bioengineered. 2020;11(1):91–102.
   PubMed Web of Science ®Google Scholar
• Chen Y, Lu B, Yang Q, et al. Combined integrin phosphoproteomic analyses and small interfering RNA–based functional screening identify key regulators for cancer cell adhesion and migration. Cancer Res. 2009;69(8):3713–3720.
   PubMed Web of Science ®Google Scholar
• Zhu X, Zhang H, Xu J. Long noncoding RNA SNHG20 regulates cell migration, invasion, and proliferation via the microRNA-19b-3p/RAB14 axis in oral squamous cell carcinoma. Bioengineered. 2021;12(1):3993–4003.
   PubMed Web of Science ®Google Scholar
• Chen J, Huang X, Wang W, et al. LncRNA CDKN2BAS predicts poor prognosis in patients with hepatocellular carcinoma and promotes metastasis via the miR-153-5p/ARHGAP18 signaling axis. Aging (Albany NY). 2018;10(11):3371–3381.
   PubMedGoogle Scholar
• Fu D, Lu C, Qu X, et al. LncRNA TTN-AS1 regulates osteosarcoma cell apoptosis and drug resistance via the miR-134-5p/MBTD1 axis. Aging (Albany NY). 2019;11(19):8374–8385.
   PubMedGoogle Scholar
• Jia Y, Duan Y, Liu T, et al. LncRNA TTN-AS1 promotes migration, invasion, and epithelial mesenchymal transition of lung adenocarcinoma via sponging miR-142-5p to regulate CDK5. Cell Death Dis. 2019;10(8):573.
   PubMed Web of Science ®Google Scholar
• Wang Y, Jiang F, Xiong Y, et al. LncRNA TTN-AS1 sponges miR-376a-3p to promote colorectal cancer progression via upregulating KLF15. Life Sci. 2020;244:116936.
   PubMed Web of Science ®Google Scholar
• Li L, Mou YP, Wang YY, et al. miR-199a-3p targets ETNK1 to promote invasion and migration in gastric cancer cells and is associated with poor prognosis. Pathol Res Pract. 2019;215(9):152511.
   PubMed Web of Science ®Google Scholar
• Liu J, Liu B, Guo Y, et al. MiR-199a-3p acts as a tumor suppressor in clear cell renal cell carcinoma. Pathol Res Pract. 2018;214(6):806–813.
   PubMed Web of Science ®Google Scholar
• Hong D, Fritz AJ, Gordon JA, et al. RUNX1-dependent mechanisms in biological control and dysregulation in cancer. J Cell Physiol. 2019;234(6):8597–8609.
   PubMed Web of Science ®Google Scholar
• Fu Y, Sun S, Man X, et al. Increased expression of RUNX1 in clear cell renal cell carcinoma predicts poor prognosis. PeerJ. 2019;7:e7854.
   PubMed Web of Science ®Google Scholar
• Keita M, Bachvarova M, Morin C, et al. The RUNX1 transcription factor is expressed in serous epithelial ovarian carcinoma and contributes to cell proliferation, migration and invasion. Cell Cycle. 2013;12(6):972–986.
   PubMed Web of Science ®Google Scholar
• Zhou T, Luo M, Cai W, et al. Runt-related transcription factor 1 (RUNX1) promotes TGF-β-induced renal tubular Epithelial-to-Mesenchymal Transition (EMT) and Renal Fibrosis through the PI3K Subunit p110δ. EBioMedicine. 2018;31:217–225.
   PubMed Web of Science ®Google Scholar
• Alonso-Alconada L, Muinelo-Romay L, Madissoo K, et al. Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer. Mol Cancer. 2014;13(1):223.
   PubMed Web of Science ®Google Scholar
• Chang K, Wang G, Lou J, et al. lncRNA TTN‑AS1 upregulates RUNX1 to enhance glioma progression via sponging miR‑27b‑3p. Oncol Rep. 2020;44(3):1064–1074.
   PubMed Web of Science ®Google Scholar
• Li Q, Sun Q, Zhu B. <p>LncRNA XIST inhibits the progression of oral squamous cell carcinoma via Sponging miR-455-3p/BTG2 Axis. Onco Targets Ther. 2020;13:11211–11220.
   PubMed Web of Science ®Google Scholar
• Xia YC, Cao J, Yang J, et al. lncRNA TSPEAR-AS2, a novel prognostic biomarker, promotes oral squamous cell carcinoma progression by upregulating PPM1A via Sponging miR-487a-3p. Dis Markers. 2021;2021:2217663.
   PubMed Web of Science ®Google Scholar
• Sarode SC, Sarode GS, Sengupta N, et al. Adipocyte-tumor cell native encounter in oral squamous cell carcinoma. Future Oncol. 2020;16(24):1793–1796.
   PubMed Web of Science ®Google Scholar
• Palazzo E, Morasso MI, Pincelli C. Molecular approach to cutaneous squamous cell carcinoma: from pathways to therapy. Int J Mol Sci. 2020;21(4):4.
   Web of Science ®Google Scholar
• Oshimori N. Cancer stem cells and their niche in the progression of squamous cell carcinoma. Cancer Sci. 2020;111(11):3985–3992.
   PubMed Web of Science ®Google Scholar